The global DNA methylation market size was valued at US$ 1.9 Bn in 2025 and is projected to reach US$ 7.7 Bn by 2036, growing ...

A researcher at the IU Indianapolis Fairbanks School of Public Health has identified a set of novel biomarkers that could significantly improve early detection of pancreatic cancer, a disease with a ...

The study evaluated the Galleri® MCED test across a large cohort of 111,080 participants in real-world healthcare settings, ...

New study shows that cancer damages its own DNA by pushing key genes to work too hard. Researchers found that the most ...

Researchers have discovered how cells activate a last-resort DNA repair system when severe damage strikes. When genetic tangles overwhelm normal repair pathways, cells flip on a fast but error-prone ...

A whole-genome sequencing approach shows early promise over current commercial methods for identifying more patients likely ...

CLEVELAND, Ohio — Pancreatic cancer stands apart from many common cancers for a troubling reason: There is no standard screening test to catch the disease early, when treatment is most effective. That ...

Researchers at Moffitt Cancer Center have developed a new way to predict how cancer cells evolve by gaining and losing whole ...

A personalized blood test known as a circulating tumor DNA (ctDNA) test—which detects tiny fragments of cancer DNA ...

TAMPA, Fla. — Doctors have been sounding the alarm for years that colorectal cancer is increasing at an alarming rate in people younger than 50. Now, legislation has been introduced at the federal ...

A new AI tool called DOLPHIN exposes hidden genetic markers inside single cells, enabling earlier detection and more precise treatment choices. It also sets the stage for building virtual models of ...